{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:18:03Z","timestamp":1787026683985,"version":"build-2736575974"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013489","name":"Yakult Bio-Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Beh\u00e7et's disease (BD) is a rare inflammatory condition characterized by oral and genital ulcers, skin lesions, as well as ophthalmological, neurological, and gastrointestinal manifestations. BD involving the gastrointestinal tract is known as intestinal BD. The mucosa of the gastrointestinal tract of patients with intestinal BD exhibits enhanced levels of proinflammatory cytokines, such as IL-1\u03b2, IL-6, and TNF-\u03b1. These proinflammatory cytokines play pathogenic roles in the development of BD, as evidenced by the fact that biologics targeting these cytokines effectively induce BD remission. It should be noted, however, that the molecular mechanisms by which the blockade of these cytokines suppresses chronic inflammatory responses in BD are poorly understood. Herein, we report a case of intestinal BD resistant to prednisolone that was successfully treated with infliximab (IFX). The induction of remission by IFX was accompanied by a marked elevation of IL-6 and forkhead box P3 (FOXP3) at mRNA level. This case suggests that induction of remission by IFX is mediated not only by the suppression of TNF-\u03b1-mediated signaling pathways, but also by the promotion of IL-6 expression and accumulation of regulatory T cells expressing FOXP3.<\/jats:p>","DOI":"10.3389\/fmed.2021.679237","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:21:03Z","timestamp":1620951663000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Case Report: A Case of Intestinal Beh\u00e7et's Disease Exhibiting Enhanced Expression of IL-6 and Forkhead Box P3 mRNA After Treatment With Infliximab"],"prefix":"10.3389","volume":"8","author":[{"given":"Keisuke","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikue","family":"Sekai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryutaro","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kurimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Masuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoe","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Minaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoriaki","family":"Komeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Chikugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12328-014-0488-0","article-title":"Diagnosis and management of intestinal Behcet's disease","volume":"7","author":"Hisamatsu","year":"2014","journal-title":"Clin J Gastroenterol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41927-020-00172-1","article-title":"Diagnosis of Behcet's disease: clinical characteristics, diagnostic criteria, and differential diagnoses","volume":"5","author":"Kiafar","year":"2021","journal-title":"BMC Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.imlet.2017.08.008","article-title":"Interleukin-26 is overexpressed in Behcet's disease and enhances Th17 related -cytokines","volume":"190","author":"Kaabachi","year":"2017","journal-title":"Immunol Lett."},{"key":"B4","article-title":"Low-dose IL-2 effectively restored decreased regulatory T cells in patients with Behcet's disease","author":"Liu","year":"2020","journal-title":"Clin Exp Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"8055","DOI":"10.1002\/jcp.27576","article-title":"Behcet's disease: an immunogenetic perspective","volume":"234","author":"Salmaninejad","year":"2019","journal-title":"J Cell Physiol."},{"key":"B6","first-page":"S149","article-title":"Anti-cytokine biologic treatment beyond anti-TNF in Behcet's disease","volume":"32","author":"Arida","year":"2014","journal-title":"Clin Exp Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1365-2567.2008.02839.x","article-title":"Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease","volume":"125","author":"Ricciardelli","year":"2008","journal-title":"Immunology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1084\/jem.20151255","article-title":"Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis","volume":"213","author":"Nguyen","year":"2016","journal-title":"J Exp Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.4049\/jimmunol.1700060","article-title":"Chronic fibro-inflammatory responses in autoimmune pancreatitis depend on IFN-alpha and IL-33 produced by plasmacytoid dendritic cells","volume":"198","author":"Watanabe","year":"2017","journal-title":"J Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/intimm\/dxz045","article-title":"RICK\/RIP2 is a NOD2-independent nodal point of gut inflammation","volume":"31","author":"Watanabe","year":"2019","journal-title":"Int Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","article-title":"Translating IL-6 biology into effective treatments","volume":"16","author":"Choy","year":"2020","journal-title":"Nat Rev Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","article-title":"Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis","volume":"118","author":"Rakoff-Nahoum","year":"2004","journal-title":"Cell."},{"key":"B13","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/rheumatology\/kex480","article-title":"Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behcet's disease: multicentre retrospective study","volume":"57","author":"Atienza-Mateo","year":"2018","journal-title":"Rheumatology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.coi.2020.07.004","article-title":"New treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression","volume":"67","author":"Mikami","year":"2020","journal-title":"Curr Opin Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1084\/jem.20070719","article-title":"All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation","volume":"204","author":"Benson","year":"2007","journal-title":"J Exp Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2005.06.029","article-title":"Molecular determinants of crosstalk between nuclear receptors and toll-like receptors","volume":"122","author":"Ogawa","year":"2005","journal-title":"Cell."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","article-title":"Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases","volume":"140","author":"Strober","year":"2011","journal-title":"Gastroenterology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1172\/JCI39481","article-title":"NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway","volume":"120","author":"Watanabe","year":"2010","journal-title":"J Clin Invest."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.679237\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:21:10Z","timestamp":1620951670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.679237\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":19,"alternative-id":["10.3389\/fmed.2021.679237"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.679237","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]},"article-number":"679237"}}